Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
171 participants
OBSERVATIONAL
2008-12-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Targon FN (Aesculap) is a new plate-screw system and available on the market since 2007. In contrast to the DHS, which uses only one telescrew, the Targon FN provides up to four telescrews.
With this registry, we want to evaluate the results of Targon FN compared with DHS systems.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Targon FN
No interventions assigned to this group
DHS
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* femoral neck fractures needing surgical therapy
* femoral head preserving indication
* Living in a 100 km Radius from Hospital
Exclusion Criteria
* Previous fracture or surgery on ipsilateral hip
* pathological fracture
* open fracture
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aesculap AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Helwig, Dr.
Role: STUDY_CHAIR
University Hospital Freiburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitaetsklinikum Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Berufsgenossenschaftliche Klinik
Tübingen, Baden-Wurttemberg, Germany
Klinikum Bad Hersfeld GmbH
Bad Hersfeld, Hesse, Germany
Evangelisches Krankenhaus
Castrop-Rauxel, North Rhine-Westphalia, Germany
Raphaelsklinik
Münster, North Rhine-Westphalia, Germany
Marienkrankenhaus Schwerte gGmbH
Schwerte, North Rhine-Westphalia, Germany
Erzgebirgsklinikum Annaberg gGmbH
Annaberg-Buchholz, Saxony, Germany
Krankenhaus Bethel
Berlin, State of Berlin, Germany
BGU Ludwigshafen
Ludwigshafen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAG-O-H-0806
Identifier Type: -
Identifier Source: org_study_id